Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Liabilities from Discontinued Operations (2016 - 2024)

Avanos Medical's Liabilities from Discontinued Operations history spans 4 years, with the latest figure at 52900000.0 for Q3 2024.

  • For Q3 2024, Liabilities from Discontinued Operations rose 2016.0% year-over-year to 52900000.0; the TTM value through Sep 2024 reached 52900000.0, up 2016.0%, while the annual FY2023 figure was 63700000.0, 797.18% up from the prior year.
  • Liabilities from Discontinued Operations for Q3 2024 was 52900000.0 at Avanos Medical, roughly flat from 52700000.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 63700000.0 in Q4 2023 and bottomed at 2500000.0 in Q3 2023.
  • The 3-year median for Liabilities from Discontinued Operations is 52450000.0 (2024), against an average of 38516666.67.
  • The largest annual shift saw Liabilities from Discontinued Operations skyrocketed 797.18% in 2023 before it soared 2016.0% in 2024.
  • A 3-year view of Liabilities from Discontinued Operations shows it stood at 7100000.0 in 2022, then surged by 797.18% to 63700000.0 in 2023, then dropped by 16.95% to 52900000.0 in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Liabilities from Discontinued Operations are 52900000.0 (Q3 2024), 52700000.0 (Q2 2024), and 52200000.0 (Q1 2024).